Websites, domains, hosts that links to amgenmedinfo.com
Our database shows, that the website amgenmedinfo.com is linked by a total of 8 websites.
Number of websites/domains displayed: 8
Results found: 8
Websites discovered:
IMLYGIC® (talimogene laherparepvec) Oncolytic Viral Therapyhttp://pageoverview.com/website-report/imlygic.com
Find information about IMLYGIC® (talimogene laherparepvec), including details about administration, storage, safety information and more.
- Expected expiration: March 29th in 2018
- Creation date: March 29th in 2012
- Renew date: February 25th in 2017
Amgenhttp://pageoverview.com/website-report/onyx.com
- Expected expiration: August 6th in 2017
- Creation date: August 7th in 1997
- Renew date: July 5th in 2016
- Google Analytics: 22843556-1
Repatha® (evolocumab) Official HCP Site | Repatha® (evolocumab)http://pageoverview.com/website-report/repathahcp.com
Learn about PCSK9 inhibitor Repatha®. Or get patients started with insurance verification, and financial assistance.
- Expected expiration: February 4th in 2023
- Creation date: February 4th in 2015
- Renew date: January 3rd in 2018
Vectibix® (panitumumab) for Wild-Type RAS mCRC | HCPhttp://pageoverview.com/website-report/vectibix.com
Learn about Vectibix® (panitumumab): an FDA-approved 1st- & 3rd-line treatment option for patients with WT RAS metastatic colorectal cancer (mCRC).
- Expected expiration: October 5th in 2018
- Creation date: October 5th in 2005
- Renew date: September 3rd in 2017
Amgenhttp://pageoverview.com/website-report/amgen.com
- Expected expiration: July 26th in 2023
- Creation date: July 27th in 1990
- Renew date: September 17th in 2015
- Google Analytics: 22843556-1
www.sensiparhcp.comhttp://pageoverview.com/website-report/sensiparhcp.com
- Expected expiration: May 13th in 2019
- Creation date: May 13th in 2009
- Renew date: April 10th in 2012
NEUPOGEN® (filgrastim) | Granulocyte Colony-Stimulating Factorhttp://pageoverview.com/website-report/neupogenhcp.com
Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration options.
- Expected expiration: December 14th in 2018
- Creation date: December 14th in 2012
- Renew date: November 12th in 2017